BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32687147)

  • 1. Cardiovascular pharmacotherapy in older people: challenges posed by cardiovascular drug prescription in the elderly.
    Kaski JC; Tamargo J; Savarese G
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):277-279. PubMed ID: 32687147
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards appropriate polypharmacy in older cardiovascular patients: How many medications do I have to take?
    Disdier Moulder MPA; Hendricks AK; Ou NN
    Clin Cardiol; 2020 Feb; 43(2):137-144. PubMed ID: 31825133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription refill management and its effect on adherence: comment on "the implications of therapeutic complexity on adherence to cardiovascular medications".
    Salanitro AH; Kripalani S
    Arch Intern Med; 2011 May; 171(9):822-3. PubMed ID: 21220643
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimization of Drug Prescription and Medication Management in Older Adults with Cardiovascular Disease.
    Wenger NK; Doherty CL; Gurwitz JH; Hirsch GA; Holmes HM; Maurer MS; Murray MD
    Drugs Aging; 2017 Nov; 34(11):803-810. PubMed ID: 29110264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy in Cardiovascular Medicine: Problems and Promises!
    Abolbashari M; Macaulay TE; Whayne TF; Mukherjee D; Saha S
    Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):31-39. PubMed ID: 28552061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop.
    Schwartz JB; Schmader KE; Hanlon JT; Abernethy DR; Gray S; Dunbar-Jacob J; Holmes HM; Murray MD; Roberts R; Joyner M; Peterson J; Lindeman D; Tai-Seale M; Downey L; Rich MW
    J Am Geriatr Soc; 2019 Feb; 67(2):371-380. PubMed ID: 30536694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA.
    Sheikh-Taha M; Dimassi H
    BMC Cardiovasc Disord; 2017 Jul; 17(1):189. PubMed ID: 28716041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
    Sokol KC; Knudsen JF; Li MM
    J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular pharmacotherapy in the aged].
    Baumhäkel M; Böhm M
    Internist (Berl); 2003 Aug; 44(8):943-50. PubMed ID: 14671808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the pharmacotherapy of vascular surgery patients by medication reconciliation.
    Hohn N; Langer S; Kalder J; Jacobs MJ; Marx G; Eisert A
    J Cardiovasc Surg (Torino); 2014 Apr; 55(2 Suppl 1):175-81. PubMed ID: 24796911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-related problems in the elderly].
    Bor A; Matuz M; Doró P; Viola R; Soós G
    Orv Hetil; 2012 Dec; 153(49):1926-36. PubMed ID: 23204299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy: the challenge for nurses.
    Kaufman G
    Nurs Stand; 2016 May; 30(39):52-60. PubMed ID: 27224631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study.
    Cordero A; Rodriguez Padial L; Batalla A; López Barreiro L; Torres Calvo F; Castellano JM; Ruiz E; Bertomeu-Martínez V;
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27957818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interactions of cardiac and antiretroviral medication].
    Egger S; Drewe J
    Herz; 2005 Sep; 30(6):493-503. PubMed ID: 16170680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of heart failure in the elderly: adverse events.
    Rich MW
    Heart Fail Rev; 2012 Sep; 17(4-5):589-95. PubMed ID: 21688185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of pharmacogenomics in elderly patients treated for cardiovascular diseases.
    Božina N; Vrkić Kirhmajer M; Šimičević L; Ganoci L; Mirošević Skvrce N; Klarica Domjanović I; Merćep I
    Croat Med J; 2020 Apr; 61(2):147-158. PubMed ID: 32378381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy adherence and drug-drug interactions in the aging HIV population.
    Nachega JB; Hsu AJ; Uthman OA; Spinewine A; Pham PA
    AIDS; 2012 Jul; 26 Suppl 1():S39-53. PubMed ID: 22781176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular drug therapy in the elderly: benefits and challenges.
    Fleg JL; Aronow WS; Frishman WH
    Nat Rev Cardiol; 2011 Jan; 8(1):13-28. PubMed ID: 20978470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriate pharmacological treatment in older adults affected by cardiovascular disease and other chronic comorbidities: a systematic literature review to identify potentially inappropriate prescription indicators.
    Lucenteforte E; Lombardi N; Vetrano DL; La Carpia D; Mitrova Z; Kirchmayer U; Corrao G; Lapi F; Mugelli A; Vannacci A
    Clin Interv Aging; 2017; 12():1761-1778. PubMed ID: 29089750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rules for improving pharmacotherapy in older adult patients: part 1 (rules 1-5).
    Wooten JM
    South Med J; 2015 Feb; 108(2):97-104. PubMed ID: 25688894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.